PubMed Health⌕ Search

PubMed · 7337922

A computerized follow-up system for hemoccult screening programs.

Abstract

Prior to the development of the CSFS, the logistics of hemoccult stool screening required many hours of clerical and secretarial time. In order to conduct multiple county, multiple location screening programs, the CSFS has been developed as a specialized application of the Roswell Park Management System (RPMIS). CSFS uses the RPMIS for formatted video data entry and editing and for report production. This system makes it possible to generate forms and letters for all patients and physicians by typing a single command. The computer output also includes cross checks for errors and updating reminders. Using non-computerized methods, 363 patients required 157 hours. The most recent 74 patients screened required less than two hours. This significant streamlining of the workload will allow for more effective utilization of this currently available screening test.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S P Colombano, J T Evans. 1980. A computerized follow-up system for hemoccult screening programs.. https://pubmed.ncbi.nlm.nih.gov/7337922/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Are there two sides to colorectal cancer?

Colorectal carcinomas (CRC) that arise proximal (right) or distal (left) to the splenic flexure exhibit differences in incidence according to geographic region, age and gender. Together with observations that tumours in the hereditary cancer syndromes HNPCC and FAP occur predominantly in the right and left colon, respectively, the existence of 2 categories of CRC based on site of origin in the large bowel was proposed more than a decade ago. Differences between normal right and left colonic segments that could favour progression through different tumourigenic pathways are summarized in this review. Accumulating evidence suggests that the risk of CRC conferred by various environmental and genetic factors is different for proximal and distal tumours. Right- and left-sided tumours also exhibit different sensitivities to fluorouracil-based chemotherapy. Such differences are probably related to the molecular characteristics of the tumours, with the microsatellite instability and CpG island methylator phenotypes being associated with right-sided tumours and chromosomal instability with left-sided tumours. Future molecular-based classification systems for CRC that rely upon distinctive gene expression patterns may allow a clearer discrimination of subgroups than that provided by tumour site alone. Until then however, the existence of 2 broadly different groups of cancer defined by site of origin in the colon should be considered in the design of future epidemiologic studies as well as in the design of new clinical trials aimed at testing novel adjuvant therapies.

Colonic Neoplasms↗